shown in Table. The study was in accordance with the declaration of Helsinki and approved by the Institutional Review Board. All patients gave written informed consent. The LAAs were removed using an endoscopic stapling device (Endo Gia stapler, Tyco Healthcare Group). The tissue samples were transported to the optical mapping setup in 100-mL cooled superfusion fluid (Na + , 155.5 mmol/L; K + , 4.7 mmol/L; Ca 2+ , 1.45 mmol/L; Mg 2+ , 0.6 mmol/L; Cl − , 136.6 mmol/L; HCO 3 − , 27 mmol/L; PO 4 3− , 0.4 mmol/L; glucose, 11.1 mmol/L; and heparin, 1000 IE).
Optical Mapping
Preparations were submerged in a tissue bath. The superfusion fluid was kept at a temperature of 36.5°C to 37.5°C and oxygenized with a mixture of 95% O 2 and 5% CO 2 to maintain a pH of 7.4. All LAAs were stimulated at 100 beats per minute at twice diastolic threshold with a pulse width of 2 ms using an epicardial electrode. In 6 LAA preparations, short-coupled premature stimuli were applied and optical mapping recordings were made of the shortest conducting S1-S2 interval. The preparation was equilibrated for ≥30 minutes. Di-4-ANEPPS (Tebu Bio) was used as a membrane potential-sensitive fluorescent dye. A contraction uncoupler 2 to 10 mmol/L 2-3-butanedione monoxime (DAM; Sigma-Aldrich, B0753) was added if motion artifacts precluded recording of fluorescent action potentials (n=7). A MiCAM Ultima camera (SciMedia USA Ltd) was used to record epicardial images of an area of 1 cm 2 with a resolution of 100×100 pixels and a sample time of 0.5 ms. Images were stored using MiCAM Ultima Experiment Manager. A custom-made analysis program based on MATLAB R2006b (The MathWorks, Inc) was used to construct epicardial activation maps. The occurrence of motion artifacts precluded analysis of the repolarization of the LAA.
Measurement of Conduction Velocity
Local activation times (ATs) were determined from the steepest upstrokes of the optical action potential at each pixel. Activation maps were constructed from local ATs. To assess conduction velocity (CV), a line was drawn in the activation map in the direction of the activation wavefront ( Figure 1 ). Subsequently, ATs were plotted against the distance from the stimulation site. This relation allowed for identification of the latency close to the stimulation site and breakthrough of multiple wave fronts at larger distance of the stimulation site. CV was calculated from the slope of the linear portion of the relation between distance to the stimulation site and AT. Local longitudinal CV (CV L ) and local transverse CV (CV T ) were calculated from the line starting at the point of earliest activation along, which activation spread most rapidly, and the line perpendicular to that respectively, assuming that this represented fiber direction. In addition, to assess the influence of fibrotic barriers on gross transverse conduction delay in the LAA, the AT was measured along an arbitrarily chosen 2-mm line on the activation maps perpendicular to the fiber direction at the site of greatest transverse conduction slowing ( Figure 1 ).
Collagen Quantification and Organization
After optical mapping, the LAAs were frozen at −80°C with liquid nitrogen. Slides were prepared from the recording area of the LAA. Picrosirius red staining was performed for visualization and quantification of interstitial collagen in 32 LAAs. Three to 5 photographs from each section of randomly selected areas were taken of nonoverlapping fields at ×10 magnification. The percentage of interstitial collagen of the total tissue (collagen and cardiomyocytes) was determined, after manual exclusion of epicardial, endocardial and perivascular fibrosis. 11, 12 Two independent observers (blinded to the origin of the sections) assessed the width of interstitial collagen strands (ICS) qualitatively ( Figure 2 ). The width of the ICS was assessed and qualified as predominantly containing either thin (±<0.01 mm) or thick fibrotic strands (±≥0.01 mm).
Fibroblast Histology
Fibroblasts were identified with antivimentin antibody (1:2000, DAKO, M0725) and an indirect peroxidase (3-amino-9-ethylcarbazole peroxidase) was used as the substrate in 27 LAAs. Sections were faintly counterstained with additional hematoxylin staining and 3 to 5 photographs of different, randomly selected areas were taken of nonoverlapping fields at ×20 magnification. The density of fibroblasts in the tissue was semiquantitatively assessed optically by 2 independent observers, blinded for section origins, based on Amiodarone, n (%) 3 (9) Calcium-antagonists, n (%) 7 (20) Echocardiographic atrial volume index, mean±SD, mL/m 2 * 41±13 AF indicates atrial fibrillation; and LAA, left atrial appendage. *Atrial volume indexed for the body surface area of the patient determined <6 mo before surgery.
WHAT IS KNOWN
• Atrial fibrosis may contribute to atrial fibrillation by separation of cardiomyocytes through extracellular matrix deposition, which may result in longer activation pathways and re-entry.
• Myofibroblasts (differentiated fibroblasts) have been suggested facilitate arrhythmogenesis by direct electric coupling to cardiomyocytes and forming a passive electric load.
WHAT THE STUDY ADDS
• The structure of atrial fibrosis, rather than the percentage, forms an arrhythmogenic substrate and is associated with conduction block and re-entry in human atrial myocardium.
• Particularly, the presence of thick strand of interstitial fibrosis are associated with the occurrence of conduction block on premature stimulation.
• Fibroblasts were abundantly present in left atrial tissue of patients with atrial fibrillation, but no myofibroblasts could be detected.
• Our study suggests a limited role of myofibroblasts once the substrate of clinical, symptomatic atrial fibrillation has developed. the density of fibroblasts scattered throughout the tissue area (excluding microvessels). Two groups were identified (intermediate, ±<30% of tissue area and many, ±>30% of tissue area). All immunohistochemical staining included the use of positive and negative controls with omission of the primary antibody and stained using the same techniques.
Myofibroblast Histology
α-smooth muscle actin (α-SMA) antibody's (1:800, Sigma, A2547) was used for staining of myofibroblasts in 27 LAAs. Because α-SMA stains pericytes and vascular smooth muscle tissue as well, an anti-CD31 antibody staining (1:500, DAKO, M0823) was performed to stain endothelial cells. Cell nuclei were stained with Sytox green (1:1000, Molecular Probes, S-7020). The combination of costaining of α-SMA and CD31 indicates microvasculature. Isolated α-SMA positive cells in the interstitium were considered to be myofibroblasts. Three to 5 photographs of different areas were taken of nonoverlapping fields at ×20 and ×40 magnification in each LAA to identify interstitial myofibroblasts. All immunohistochemical staining included the use of positive and negative controls with omission of the primary antibody and stained using the same techniques.
Statistics
Data are presented as mean±SD for normally distributed continuous variables or median and empirical limits for non-normally distributed variables. Categorical variables are presented in numbers with percentages. Differences were determined using an independent Student t test for normally distributed data or a Mann-Whitney U test for non-normally distributed data. To assess correlation in normally distributed data, the Pearson was used and in case of nonparametric data Spearmans was used. P<0.05 was considered significant. Statistical analyses were performed using IBM SPSS Statistics version 20.
Results

Conduction Velocity
Mean CV L was 0.55±0.22 m/s and mean CV T was 0.25±0.15 m/s. Median anisotropy was 3.1 (1.05-13.4). CV L and CV T were not significantly different in patients with paroxysmal or persistent AF (CV L : P=0.25 and CV T : P=0.51). Other patient characteristics were not associated with CV L or CV T . In particular, the use of sodium channel blocking drugs flecainide and amiodarone were not related to CV L (P=0.94) or CV T (P=0.14). Mean AT was 9.31±5.45 ms. AT was not different between patients with paroxysmal or persistent AF (P=0.15). Patient characteristics, including the use of sodium channel blocking drugs flecainide and amiodarone were not associated with AT (P=0.76). A total of 7 LAAs required DAM to reduce motion artifacts. CV L (P=0.47), CV T (P=0.28), and AT (P=0.62) between the LAAs exposed to DAM and other LAAs were similar.
In the 6 LAAs with premature stimulation (shortest S1-S2 interval; mean 250 ms 12 ) at shortest S1-S2 interval. AT increased significantly from 4.73 ms (3.33-6.90 ms) to 8.08 ms (4.35-13.33 ms; P=0.028). Activation maps of the shortest captured S1-S2 interval showed prolonged ATs and clear lines of conduction block, that were absent during stimulation at basic cycle length. Figure 3 shows 2 representative activation maps from the same LAA. In this LAA, the CV L was 0.46 m/s and CV T was 0.27 m/s at baseline. Note that at the short-coupled premature stimuli the activation pattern shows a zig-zag pattern, calculated CV L was 0.15 m/s and CV T was 0.13 m/s, whereas the apparent CV along line C is 0.06 m/s. However, if we follow the activation wavefront (line D), circumventing the area of conduction block, apparent CV along the activation wavefront is 0.23 m/s.
Interstitial Fibrosis
In 4 LAAs, severe artifacts precluded the semiquantitative analysis of interstitial collagen. In the remaining 28, the collagen content was 16.8±7.5%. There was no significant difference in the percentage of collagen between patients with paroxysmal and persistent AF (P=0.22). CV L and CV T were not associated with the amount of collagen (CV L : P=0.098 and CV T : P=0.91). However, a larger degree of transverse conduction delay was observed in patients with a high amount of collagen (AT: P=0.015). Other clinical characteristics of the patients, including left atrial size were not associated with the interstitial collagen content.
After qualitative assessment, 24 LAAs contained mainly thin ICS, whereas 8 LAAs had a mainly thick ICS. Thick strands were more often found in patients with a high degree of interstitial collagen content (mean 14.0% versus 21.1%; P=0.027). In addition, 7 of the 8 patients with thick ICS had persistent AF. CV L was higher in patients with thick ICS of 0.77±0.22 m/s compared with thin ICS of 0.48±0.19 m/s (P=0.012). CV T was not significantly different between samples with thick ICS and thin ICS (0.24±0.14 m/s compared with 0.22±0.16 m/s; P=0.47; Figure 4 ). However, AT was significantly higher in patients with thick ICS compared with patients with thin ICS (14.93±6.93 versus 7.95±4.12 ms; P=0.004).
Fibroblast Histology
Fibroblasts were abundantly present (intermediate, n=10 and many, n=17). A high density of fibroblasts was associated with a high CV L as shown in Figure 5 9. 67±3.95 ms versus many, 10.64±6.68 ms; P=0.90). Furthermore, all the specimens with thick ICS also had many fibroblasts (P=0.008).
Myofibroblast Histology
The combination of α-SMA and CD31 staining revealed a significant amount of interstitial atrial microvasculature, composed of CD31 positive smooth muscle cells bordered by a rim of α-SMA positive pericytes. Myofibroblasts could not be identified in the LAA (n=27) because no isolated α-SMA positive interstitial cells were present ( Figure 6 ).
Discussion
This study shows that the structural local components of fibrosis, specifically the collagenous interstitial matrix, played an important role in modulating CV L and CV T in LAAs obtained from patients undergoing antiarrhythmic surgery for AF. Patients with persistent AF or high degree of interstitial collagen had predominantly thick ICS. This was associated with increased CV L , whereas local CV T was not affected. In spite of increased CV L , more transverse activation delay was present in these preparations and areas of activation block occurred, leading to zig-zag conduction. More pronounced slowing of conduction was observed after short-coupled stimuli. They also induced lines of conduction block, which were absent under baseline stimulation. Fibroblasts were abundantly present in the human LAA, and was associated with thick ICS and a high CV L . No myofibroblasts were detected in the LAAs.
The Role of Fibrosis in the Arrhythmogenic
Substrate of AF
The patients undergoing thoracoscopic surgery for AF had a mean amount of 16.8% fibrosis. In a study investigating patients with AF with or without mitral valve disease 7.6% fibrosis was reported in the LAAs of patients with lone AF and 10.7% in patients with mitral valve disease using similar methods of fibrosis quantification. 1 The patients in our study are patients with highly symptomatic AF with an indication for surgical treatment. The high amount of fibrosis in our patients might be explained by large atria, older age, and a greater predominance of persistent AF compared with earlier studies. However, no single patient characteristic was associated with the amount of fibrosis in the LAA in our data. In our patients, the organization of interstitial collagen rather than the amount was associated with conduction changes. 9 The contribution of fibrosis to the arrhythmogenic mechanism has been extensively studied in monolayers of cultured myocytes, animal models, and in human ventricular myocardium. 4, 9, 13, 14 In our experiments, we observed the induction of activation delay, caused by propagation of the activation front around inexcitable barriers of collagen. In these LAAs, CV was only modestly affected, possibly because of increased transverse fiber separation. 4, 15 This may result in a heterogeneity of conduction, such as the occurrence of unidirectional conduction block and re-entry, facilitating both the induction and the maintenance of AF. 16 At baseline, pacing some LAAs showed a high anisotropy and activation delay. High anisotropy might facilitate the development of AF because of ectopic foci. 17 In the presence of short-coupled premature stimuli, such as during AF, lines of conduction block developed, and the activation wavefront propagated around this area of block ( Figure 3 ). CV is also determined by excitability and coupling, mediated by the voltage-gated sodium channels and connexins, respectively. 18 Therefore, we cannot fully exclude that changes in CV between patients might be related to changed function or expression of the voltage-gated sodium channels and (lateralization of) connexins. 2, 18 However, a severe reduction in functional gap junction, as well as a reduced voltagegated sodium channels would result in a reduced CV, whereas we observed an increase in CV L and a unaffected CV T . These findings illustrate the local arrhythmogenic effect of fibrosis in the pathophysiology of AF, but our data do not permit conclusions about the question whether fibrosis is a result or the cause of AF. 19 The Role of Fibroblasts in the Substrate of AF A high density of fibroblasts in the LAA was associated with thick ICS, suggesting a local increase of extracellular matrix deposition. The increased extracellular matrix results in a separation between cardiomyocytes and subsequently in an increase in CV L . 14 In in-silico models, fibroblasts have been described to act as passive electric load and to depolarize cardiomyocyte resting membrane potential through gap junctional coupling with myocytes. 7 However, only the myofibroblast, a differentiated form of the fibroblast, connects to cardiomyocytes in in-vitro cell layer models. 5, 20 This connection can result in discontinuous slow conduction and induces spontaneous electric activity. 21 Our observations argue against such a mechanism in the patients that we studied because CV L was increased in the presence of a high density of fibroblasts, which is not expected if reduced direct coupling is present. Alternatively, fibroblasts might exert their influences on CV by a paracrine mechanism. In cell-cultures, a significant paracrine effect was found on CV, resulting in reduced CV. 22 However, our data showed an increase in CV L in the presence of many fibroblasts, thus it is unlikely that the paracrine influences on CV have a major role in these patients.
The Role of Myofibroblasts in the Substrate of AF
In response to pathological stimuli, fibroblasts differentiate into myofibroblasts. 23 In our selected population of patients with symptomatic AF and enlarged atria undergoing thoracoscopic surgery for AF, no myofibroblasts were detected in the LAAs. However, myofibroblasts might play a more prominent role in other, more acute, causes of AF (eg, valvular AF, AF after ischemia, and experimental models) 24, 25 or in the earlier phases of AF. There, the myofibroblasts might contribute to an increase in extracellular matrix and subsequently differentiate to inactive fibrocytes in a later phase of the disease.
Clinical Implications
The major finding of our study is that in patients with AF, an arrhythmogenic substrate for atrial re-entry is present, caused by the deposition of collagen. It may be conceivable that thick collagen strands anchor rotors that sustain human AF. Identification of the patients with severely affected fibrotic atria might help to guide therapeutic decision-making. Recent studies using noninvasive characterization of the fibrotic phenotype using MRI have shown an inverse relation between the success of catheter ablation for AF and the amount of fibrosis present in the atrium. 26 Although present imaging techniques allow the detection of large areas of fibrosis, future developments might increase the resolution and enable the detection of smaller fibrotic strands.
Fibrosis consists of a dynamic substrate of fibroblasts and extracellular matrix in which collagen turnover is between 3% and 5% per day. 27 A reduction in extracellular matrix secretion by fibroblasts or the prevention of the formation or migration of myofibroblasts, could possibly reduce or alter the deposition of collagen and could be a potential target of upstream therapy. Studies already have already demonstrated a moderate effect of upstream therapy in the setting of primary prevention. 28 However, it is unclear whether secondary prevention can induce reverse remodeling and dissolve this arrhythmogenic substrate. 29
Limitations
Because of the nature of surgery, we could obtain only LAAs, but no left atrial samples without cardioplegia for the electrophysiological experiments. Also, we were not able to obtain tissue from healthy control patients. It is unclear whether the LAA myocytes are different from the rest of the atrium. The distribution and amount of interstitial collagen in the LAA probably reflects the fibrotic changes in the left atrium, although no study has investigated the distribution of fibrotic remodeling throughout the entire human atrium. However, a similar amount of (increased) fibrosis was observed at different parts of the left atrium in patients with AF. 30 Our model of the LAA provides a unique opportunity to study the atrial substrate in patients with AF.
All patients underwent the procedure under general anesthesia and remained on antiarrhythmic drugs. These drugs could have influenced the electrophysiological findings in the LAA. However, no relation of the antiarrhythmic drugs with CV, especially sodium channel blocking drugs was observed.
After administration of DAM to the superfusion medium, a certain degree of motion artifact remained. Although DAM can influence the electrophysiological properties of the LAA, the LAA samples that received DAM were limited (n=7), were evenly distributed among the groups and did not deviate from results of samples without DAM. Because of motion artifacts induced by LAA contraction, determination of action potential characteristics other than the upstroke (ie, repolarization) could not be reliably performed.
Conclusions
In patients undergoing thoracoscopic surgery for AF, the structural local interstitial components of fibrosis modulate conduction in the LAA. Patients with persistent AF had more thick interstitial fibrotic strands, which was associated with an increased longitudinal CV, consistent with a separation of myocardial fibers. Local transverse conduction was not affected by these fibrotic strands, but activation delay was present because of areas of activation block. Slowing of conduction and increased areas of conduction block were observed after short-coupled stimuli, but were absent under baseline stimulation. Fibroblasts were abundantly present in the human LAA and were associated with thick interstitial fibrotic strands and increased longitudinal conduction. However, myofibroblasts were absent in the human LAAs. Our observations demonstrate that the severity and structure of local interstitial fibrosis is associated with atrial conduction abnormalities, presenting an arrhythmogenic substrate for atrial re-entry.
